Literature DB >> 22031609

Prostatitis.

J Curtis Nickel1.   

Abstract

Entities:  

Year:  2011        PMID： 22031609      PMCID： PMC3202001          DOI： 10.5489/cuaj.11211

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  51 in total

1.  EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU).

Authors:  K G Naber; B Bergman; M C Bishop; T E Bjerklund-Johansen; H Botto; B Lobel; F Jinenez Cruz; F P Selvaggi
Journal:  Eur Urol       Date:  2001-11       Impact factor: 20.096

2.  A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS).

Authors:  Volkan Tuğcu; Ali Ihsan Taşçi; Adem Fazlioğlu; Gökhan Gürbüz; Emin Ozbek; Selçuk Sahin; Fatih Kurtuluş; Mete Cek
Journal:  Eur Urol       Date:  2006-10-17       Impact factor: 20.096

3.  Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.

Authors:  Daniel A Shoskes; J Curtis Nickel; Michael W Kattan
Journal:  Urology       Date:  2010-04-03       Impact factor: 2.649

4.  A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Sylvia M Bates; Valerie A Hill; John B Anderson; Christopher R Chapple; Rosemary Spence; Claire Ryan; Martin D Talbot
Journal:  BJU Int       Date:  2007-02       Impact factor: 5.588

Review 5.  Phenotypic approach to the management of the chronic prostatitis/chronic pelvic pain syndrome.

Authors:  J Curtis Nickel; Daniel A Shoskes
Journal:  BJU Int       Date:  2010-11       Impact factor: 5.588

6.  Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.

Authors:  J Curtis Nickel; Joe Downey; Janet Clark; Richard W Casey; Peter J Pommerville; Jack Barkin; Gary Steinhoff; Gerald Brock; Allan B Patrick; Stanley Flax; Bernard Goldfarb; Bruce W Palmer; Joseph Zadra
Journal:  Urology       Date:  2003-10       Impact factor: 2.649

7.  A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.

Authors:  Steven A Kaplan; Michael A Volpe; Alexis E Te
Journal:  J Urol       Date:  2004-01       Impact factor: 7.450

8.  Treatment for chronic prostatitis/chronic pelvic pain syndrome: levofloxacin, doxazosin and their combination.

Authors:  Chang Wook Jeong; Dae Jung Lim; Hwancheol Son; Sang Eun Lee; Hyeon Jeong
Journal:  Urol Int       Date:  2008-03-19       Impact factor: 2.089

9.  Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.

Authors:  J Curtis Nickel; Perinchery Narayan; John McKay; Caroline Doyle
Journal:  J Urol       Date:  2004-04       Impact factor: 7.450

Review 10.  Clinical evaluation of the man with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  J Curtis Nickel
Journal:  Urology       Date:  2002-12       Impact factor: 2.649
View more
  19 in total

Review 1.  Evaluation of the male with chronic prostatitis/chronic pelvic pain syndrome.

Authors:  R Christopher Doiron; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2018-06       Impact factor: 1.862

Review 2.  Management of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  R Christopher Doiron; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2018-06       Impact factor: 1.862

3.  Do antibiotics decrease prostate-specific antigen levels and reduce the need for prostate biopsy in type IV prostatitis? A systematic literature review.

Authors:  Karel T Buddingh; Marlies G F Maatje; Hein Putter; René F Kropman; Rob C M Pelger
Journal:  Can Urol Assoc J       Date:  2017-12-01       Impact factor: 1.862

4.  Lower urinary tract symptoms associated with prostatitis.

Authors:  J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

5.  An unusual cause of hematospermia: Primary adenocarcinoma of the seminal vesicle.

Authors:  Alper Eken; Volkan Izol; I Atilla Aridogan; Seyda Erdogan; Arbil Acıkalın; Zuhtu Tansug
Journal:  Can Urol Assoc J       Date:  2012-12       Impact factor: 1.862

6.  The evolving clinical picture of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A look at 1310 patients over 16 years.

Authors:  R Christopher Doiron; Dean A Tripp; Victoria Tolls; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2018-02-23       Impact factor: 1.862

Review 7.  Management of Chronic Prostatitis (CP).

Authors:  Nadir Zaidi; Dominique Thomas; Bilal Chughtai
Journal:  Curr Urol Rep       Date:  2018-08-31       Impact factor: 3.092

8.  Chronic oral exposure to glycated whey proteins increases survival of aged male NOD mice with autoimmune prostatitis by regulating the gut microbiome and anti-inflammatory responses.

Authors:  Yingjia Chen; Kevin M Guo; Tamas Nagy; Tai L Guo
Journal:  Food Funct       Date:  2020-01-29       Impact factor: 5.396

9.  Paucisymptomatic infectious prostatitis as a cause of fever without an apparent origin. A series of 19 patients.

Authors:  I Novo-Veleiro; M Hernández-Cabrera; F Cañas-Hernández; E Pisos-Álamo; A Francés-Urmeneta; M Delgado-Yagüe; L Alvela-Suárez; J-L Pérez-Arellano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-09-06       Impact factor: 3.267

Review 10.  Cellular senescence as a possible link between prostate diseases of the ageing male.

Authors:  Gaelle Fiard; Vasilis Stavrinides; Emma S Chambers; Susan Heavey; Alex Freeman; Rhys Ball; Arne N Akbar; Mark Emberton
Journal:  Nat Rev Urol       Date:  2021-07-22       Impact factor: 14.432
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.